Ocean Biomedical, Inc.
NASDAQ:OCEA
0.98 (USD) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 0 | 33.933 | 0.049 | 0.035 |
| General & Administrative Expenses
| 0 | 28.412 | 1.603 | 0.197 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 |
| SG&A
| 2.482 | 28.412 | 1.603 | 0.197 |
| Other Expenses
| 2.482 | 0.001 | -0.001 | 0 |
| Operating Expenses
| 2.482 | 62.345 | 1.652 | 0.232 |
| Operating Income
| -2.482 | -62.345 | -1.652 | -0.232 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 1.523 | 0.001 | -0.001 | 0 |
| Income Before Tax
| -0.958 | -62.344 | -1.653 | -0.232 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 |
| Income Tax Expense
| -1.524 | -0.237 | -0.206 | -0.172 |
| Net Income
| 0.565 | -62.344 | -1.653 | -0.232 |
| Net Income Ratio
| 0 | 0 | 0 | 0 |
| EPS
| 0.043 | -4.71 | -0.082 | -0.012 |
| EPS Diluted
| 0.043 | -4.71 | -0.082 | -0.012 |
| EBITDA
| -0.958 | -62.345 | -1.652 | -0.232 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 |